MLBON.PA bonyf N.V. (EURONEXT) €3.96 27 Jan 2026 after hours: oversold bounce may offer 23.06% upside
We see an oversold bounce setup in MLBON.PA stock after the share price settled at €3.96 in after-hours trade on 27 Jan 2026. The microcap listed on EURONEXT has plunged from a €19.50 year high and now trades well below its 50-day average of €9.20 and 200-day average of €12.73. Volume spiked to 280 versus an average of 8, giving a relative volume of 35.00 and signalling short-term attention. As an AI-powered market analysis platform, Meyka AI flags this as a high-volatility, high-reward bounce candidate for traders ready to manage risk.
Price action and oversold setup for MLBON.PA stock
MLBON.PA stock closed the regular session at €3.96 and showed no intraday change, marking the year low. The one-year change is -78.24%, and the three-month change is -69.30%, which meets oversold criteria for mean-reversion strategies. The small float and microcap market cap of €2,330,856.00 magnify moves and can produce sharp bounces on modest volume increases.
Financials and valuation snapshot
bonyf N.V. reports an EPS of -1.77 and a negative PE of -2.24, reflecting recent losses. Price-to-book sits at 0.88, price-to-sales at 8.28, and free cash flow yield is 24.44%, indicating available cash generation relative to price. Current ratio is 0.51, highlighting short-term liquidity pressure that investors must monitor.
Technical indicators and trade signals
Technicals show a strong downtrend but oversold signals: 50-day average €9.20 and 200-day average €12.73 are both above price. MACD histogram is -0.16 and ADX reads 100.00, signalling a strong trending move. A short-term bounce trade would target a reclaim of €5.50 (monthly model) while respecting a tight stop below €3.60 to limit downside.
Meyka AI grade and forecast for MLBON.PA stock
Meyka AI rates MLBON.PA with a score out of 100: Score: 61.26 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12-month price of €4.87, implying +23.06% from €3.96. Forecasts are model-based projections and not guarantees.
Catalysts, sector context and headline drivers
bonyf operates in Healthcare, Medical – Instruments & Supplies, a defensive sector that has returned +6.37% over one year in our sector dataset. Catalysts that could trigger a bounce include improved receivables collection, a liquidity update, or renewed European distribution agreements. The company website lists product lines such as PerioTabs and AphtoFix; see the company site for product updates.
Risk management and a practical oversold bounce plan
Given microcap volatility, trade size should be small and stops tight. Plan one: enter partial position near €3.96, add on reclaim of €5.50, set stop at €3.60 and take partial profits at €4.87 and €6.00. Consider liquidity constraints: shares outstanding are 588,600 and intraday volume can vary widely.
Final Thoughts
MLBON.PA stock shows a classic oversold bounce profile after collapsing to €3.96 and trading at the year low on EURONEXT. Short-term upside is credible because the stock trades far below moving averages, has a high relative volume of 35.00, and a microcap market cap of €2,330,856.00 that amplifies rebounds. Meyka AI’s forecast model projects a 12-month price of €4.87, implying +23.06% versus the current price. Use a strict risk plan: small position sizes, a stop near €3.60, and staged profit targets at €4.87 and €5.50. Remember that fundamentals show negative EPS -1.77, a weak current ratio 0.51, and elevated receivables days, so upside is paired with clear liquidity and execution risks. This report is analysis, not financial advice; consider liquidity, sector dynamics, and company updates. For more details and the Meyka stock page follow our internal coverage at Meyka MLBON.PA page.
FAQs
Is MLBON.PA stock a buy after the drop?
MLBON.PA stock presents a bounce trade, not a long-term buy without improved fundamentals. Use small sizes and tight stops because EPS is -1.77, current ratio 0.51, and market cap is microcap size.
What price targets should traders watch for MLBON.PA stock?
Watch €4.87 as Meyka AI’s 12-month model target and €5.50 as a short-term monthly rebound level. Use €3.60 as a protective stop on bounce trades.
How does sector performance affect MLBON.PA stock outlook?
Healthcare sector trends are modestly positive and can support recovery. bonyf sits in Medical – Instruments & Supplies where peers show steadier margins, but microcap risks can override sector tailwinds.
What are the main risks for an oversold bounce trade in MLBON.PA stock?
Main risks include illiquidity, negative EPS -1.77, stretched receivables and a low current ratio 0.51. News on financing or distribution could widen moves either way.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
